logo
Inaugural 'Childcare Show' to Celebrate Industry and Meet Surge in Demand for Workers

Inaugural 'Childcare Show' to Celebrate Industry and Meet Surge in Demand for Workers

The Childcare Show is to be held on Wednesday May 14 from 5.30pm-8.30pm in the new £14 million Nant building at Yale in Wrexham, a health and wellbeing Centre featuring the popular Iâl Spa, simulated hospital wards and virtual reality environments.
Organised by Childcare Assessor Lauren Lawrence, a former nursery manager with more than 10 years' experience in the sector, the event is a first for the college, uniting more than 30 organisations and businesses with up to 100 students and their families, charities and relevant stakeholders.
'Ultimately it will be an opportunity for the learners and staff to showcase the amazing work that takes place here and out in the community,' said Lauren.
'We wanted to celebrate that while promoting best practice and bringing childcare providers all under one roof at our cutting-edge Nant centre to engage and encourage the next generation of workers in this arena, because there is so much demand.
'The providers see our learners in a workplace setting but not the amazing facilities we have here, so it will be fantastic to show them the building, the training, and demonstrate the academic side of our programmes.
'My vision is for there to be pockets of people gathering ideas and information, bilingual networking and groups sharing best practice, which due to the nature of the job and hours people operate – early morning until evening – they won't usually get a chance to do.
'From the interest we've had already it looks like being an incredible event, so we are excited to welcome people on the night.'
Among those in attendance will be cohorts from Levels 2 and 3 of the Children's Care, Play and Learning qualification.
Organisations including the NHS, Forest School, Wrexham Family Information Service, quality assessors and private nurseries have also signed up.
In Wales, the childcare sector faces high demand for qualified and trained practitioners, particularly for early education and childcare assistants and practitioners, due to government initiatives which have made provision more accessible.
Lauren says by working together they can make childcare a more attractive proposition for young people, given the jobs available within schools, day nurseries, the health service, play work and care settings, special needs units, the travel sector and with private families who require nannies.
'Childcare is an amazing and rewarding world to be in and can also act as a launchpad to many other areas due to the transferable skills, it is not just playing and looking after children, hence the need for these qualifications,' she said.
'There are so many options out there, but traditionally this hasn't been seen as a viable long-term career, a perception we want to change, starting with this event.
'We are already being asked to make this an annual celebration so watch this space.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Concern over weight gain after ‘skinny jabs'
Concern over weight gain after ‘skinny jabs'

STV News

time11 minutes ago

  • STV News

Concern over weight gain after ‘skinny jabs'

Health chiefs have raised concerns about people regaining weight after using Wegovy and Mounjaro, saying that patients coming off the drugs should be given support to help prevent them piling on the pounds again. Research shows that many people regain weight after stopping treatment if they are not supported, the National Institute for Health and Care Excellence (Nice) said. The health watchdog said that people coming off the drugs should be offered 'structured advice and follow-up support' to help prevent weight gain. The guidance is for people who are offered the treatments through the NHS. An estimated 1.5 million people are taking weight loss jabs in the UK, but the vast majority are paying for them privately so will not be eligible for NHS support after they have finished their treatment. Around 240,000 people with 'greatest need' are expected to receive Mounjaro, also known as tirzepatide, through the NHS over the next three years. The new 'quality standard' from Nice says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made. 'This new standard makes sure services provide that vital continuity of care, and it supports the NHS 10 Year Plan to shift from a 'sickness service' to a genuine health service focused on prevention.' Dr Rebecca Payne, chair of Nice's Quality Standards Advisory Committee, added: 'Weight management is a long-term journey, not a short-term fix. 'The evidence is clear that advice and support for maintaining weight after stopping medicines or completing behavioural interventions can help prevent weight regain and enable people to experience lasting benefits. 'We've seen excellent examples of services that already provide comprehensive discharge planning and ongoing support. 'This quality standard will help ensure all healthcare providers adopt these best practices, giving every person the best chance of maintaining their weight management success over the long term. 'This standard ensures healthcare services are equipped to provide that essential ongoing support.' Commenting, Henry Gregg, chief executive of the National Pharmacy Association, said: 'Pharmacies take their responsibilities seriously to provide full wrap-around support to patients trying to achieve a healthy weight. 'We know that although medication can be effective in speeding up weight loss in some people, it is not a silver bullet and patients need to make long-term lifestyle changes to make their weight loss sustainable. 'The current NHS rollout of weight loss treatment is very small, with only a handful of patients receiving it, and it will continue to be the case that the vast majority of eligible patients will be seen by their pharmacy.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'There is no one-size-fits-all approach to tackling obesity – what works for one patient will likely not work for another and, as with any medication, weight-loss drugs do not come without risk. 'It's also the case that patients will likely need support to sustain their weight loss once they stop taking the medication. As such, this is important and sensible guidance from Nice. 'As a college, we've been clear that whilst weight loss medications have significant potential benefits for patients who are struggling to lose weight, they mustn't be seen as a 'silver bullet' and ensuring access to sufficient 'wraparound' services – particularly for when patients come off their medication – will be key to optimal health outcomes.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country

What is RSV? The main cause of hospital admissions for children
What is RSV? The main cause of hospital admissions for children

The Independent

time41 minutes ago

  • The Independent

What is RSV? The main cause of hospital admissions for children

Health experts say the UK should brace for a surge in a potentially serious virus following a record number of cases in Australia. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. In Australia, respiratory syncytial virus (RSV) cases have surged in recent months, and officials have said that cases have been steadily increasing in England since the start of 2025. NHS England has urged pregnant women to get the vaccine, which protects against RSV, in order to protect their newborn babies. The virus is a leading cause of death among babies and the main cause of hospital admissions for children. Kate Brintworth, chief midwifery officer for NHS England, said that while for most adults, RSV 'only causes mild, cold-like symptoms, for older adults and young children, it can lead to serious breathing problems that can end up in hospitalisation'. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab, and NHS England will start inviting people to come forward in the next few weeks. Symptoms of an RSV infection NHS RSV is a common cause of coughs and colds, but some people have a high risk of getting seriously ill from the virus, including babies and adults over the age of 75. In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It said that the jab for pregnant women can prevent 72 per cent of hospital admissions for their babies. And the vaccine is 82 per cent effective at preventing hospital admissions for RSV among older adults, UKHSA said.

Respiratory Syncytial Virus: UK warning over rise in cases
Respiratory Syncytial Virus: UK warning over rise in cases

Glasgow Times

timean hour ago

  • Glasgow Times

Respiratory Syncytial Virus: UK warning over rise in cases

Respiratory Syncytial Virus (RSV) is a common cause of coughs and colds, with most children getting an RSV infection at least once before they turn two years old. However, it can cause "serious breathing problems", and following a record number of RSV cases in Australia, the UK is being warned over a similar rise here. NHS officials said that the Australian winter is often a good predictor of how viruses will spread in England. What is Respiratory Syncytial Virus? Respiratory Syncytial Virus (RSV) infections are described as "very common" by the NHS , but can cause serious illness in the elderly and young children. Despite typically being unserious, some babies and adults have a higher risk of getting seriously ill from RSV. The virus is a common cause of a type of chest infection called bronchiolitis in babies, which can cause breathing problems and may need to be treated in hospital. There is a vaccine for RSV, which, as the NHS explains, is recommended if: You're pregnant (from 28 weeks of pregnancy) – this will help protect your baby for the first few months after they're born You're aged 75 to 79 Last week, the UK Health Security Agency published data showing the efficacy of the vaccine. It was revealed that the jab for pregnant women can prevent 72% of hospital admissions for their babies. Meanwhile, the UKHSA said the vaccine is 82% effective at preventing hospital admissions for RSV among older adults. Symptoms of an RSV infection The NHS says symptoms of an RSV infection typically start within a few days of getting infected. Most people only get cold-like symptoms, such as: a runny or blocked nose a cough sneezing tiredness a high temperature – signs include your back or chest feeling hotter than usual, sweatiness and shivering (chills) It says that babies with RSV may also be irritable and feed less than usual. What is RSV? 💭 It's a respiratory virus that can cause serious illness in the elderly & young children. If a woman has the vaccination during pregnancy, it cuts the risk of serious lung infection caused by #RSV in her baby's first 6 months Read more: — UK Health Security Agency (@UKHSA) August 4, 2025 However, if the virus leads to a more serious infection (such as pneumonia or bronchiolitis), it may also cause: a cough that gets worse shortness of breath faster breathing or long gaps between breaths difficulty feeding (in babies) or loss of appetite noisy breathing (wheezing) confusion (in older adults) Warning to UK over rise in RSV cases Health experts have warned that the UK should brace for a surge in RSV following a record number of cases in Australia. Officials have said that cases have been steadily increasing in England since the start of 2025, and NHS England has urged pregnant women to get the vaccine to protect newborn babies. It said that the virus is a leading cause of death among babies and the main cause of hospital admissions for children. Kate Brintworth, chief midwifery officer for NHS England, said: 'While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Recommended reading: Pregnant women can get the jab from 28 weeks of pregnancy onwards through their maternity services or GP surgery. Older adults aged 75-79 are also eligible for the jab. NHS England will start inviting people to come forward in the next few weeks.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store